Surgical Management of Moderate to Severe Epistaxis in Hereditary Hemorrhagic Telangiectasia: Systematic Review and Meta-Analysis

被引:1
作者
Benaim, Ezer H. [1 ]
Kallenberger, Ethan M. [2 ]
Mirmozaffari, Yasine [1 ]
Klatt-Cromwell, Cristine [1 ]
Ebert Jr, Charles S. [1 ]
Kimple, Adam J. [1 ]
Senior, Brent A. [1 ]
Kasthuri, Raj S. [3 ]
Thorp, Brian D. [1 ]
机构
[1] Univ North Carolina Chapel Hill, Dept Otolaryngol Head & Neck Surg, 170 Manning Dr, Campus Box 7070, Chapel Hill, NC 27599 USA
[2] Med Univ South Carolina, Dept Otolaryngol Head & Neck Surg, Charleston, SC USA
[3] Univ North Carolina Chapel Hill, Dept Med, Div Hematol & Oncol, Chapel Hill, NC 27599 USA
关键词
hereditary hemorrhagic telangiectasia; surgery; epistaxis severity score; coagulation; laser therapy; nasal closure; septodermoplasty; transfusion; quality of life; complications; ARGON PLASMA COAGULATION; DOUBLE-BLIND; NASAL CLOSURE; ESTROGEN-TREATMENT; YOUNGS PROCEDURE; BEVACIZUMAB; SUBMUCOSAL; THERAPY; RADIOFREQUENCY; SCLEROTHERAPY;
D O I
10.1177/19458924241308952
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background Epistaxis is one of the most common and debilitating symptoms of hereditary hemorrhagic telangiectasia (HHT), significantly impacting patients' quality of life. While various medical and surgical interventions exist for managing epistaxis in patients with HHT, patients with moderate to severe epistaxis are high health-care utilizers who frequently need surgical treatment.Objective To compare the efficacy, complications, and patient-reported outcomes for common surgical interventions utilized in treating epistaxis in patients with HHTMethods Studies were identified in PubMed, Embase, Scopus, Redalyc, and LILACS databases and uploaded to Covidence. A systematic review following PRISMA guidelines was conducted on studies evaluating outcomes in adults with HHT with moderate to severe epistaxis who had undergone surgical interventions. We compared the respective outcomes for pre-operative and post-operative epistaxis severity/intensity, need for further interventions or transfusions, estimated blood loss, length of surgery, complications, and patient satisfaction.Results Twenty studies with a total of 546 patients were included. The most common surgeries studied were nasal closure and laser photocoagulation. Seven studies recorded the change in epistaxis severity score and observed a significant reduction postoperatively (3.91, [95% CI 2.73-5.09]). Eleven studies found a decrease in the number of transfusions and a rise in hemoglobin levels post-operatively. Common complications reported were partial dehiscence of a nasal closure, septal perforation, and continued bleeding requiring re-operation. Most patients report improved quality of life and satisfaction with surgical intervention.Conclusion Surgery can significantly reduce the severity of epistaxis in patients with HHT and improve quality of life. Further studies should focus on head-to-head comparisons of procedures and standardization of outcome measures.
引用
收藏
页码:159 / 168
页数:10
相关论文
共 63 条
[1]   Laser-Assisted Control of Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Systematic Review [J].
Abiri, Arash ;
Goshtasbi, Khodayar ;
Maducdoc, Marlon ;
Sahyouni, Ronald ;
Wang, Marilene B. ;
Kuan, Edward C. .
LASERS IN SURGERY AND MEDICINE, 2020, 52 (04) :293-300
[2]   An international survey to evaluate systemic bevacizumab for chronic bleeding in hereditary haemorrhagic telangiectasia [J].
Al-Samkari, Hanny ;
Albitar, Hasan A. ;
Olitsky, Scott E. ;
Clancy, Marianne S. ;
Iyer, Vivek N. .
HAEMOPHILIA, 2020, 26 (06) :1038-1045
[3]   Patient-recorded benefit from nasal closure in a Danish cohort of patients with hereditary haemorrhagic telangiectasia [J].
Andersen, Jonas Hjelm ;
Kjeldsen, Anette Drohse .
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2020, 277 (03) :791-800
[4]   Topical estrogens combined with argon plasma coagulation in the management of epistaxis in hereditary hemorrhagic telangiectasia [J].
Bergler, W ;
Sadick, H ;
Riedel, F ;
Götte, K ;
Hörmann, K .
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2002, 111 (03) :222-228
[5]   Prospective randomized trial of sclerotherapy vs standard treatment for epistaxis due to hereditary hemorrhagic telangiectasia [J].
Boyer, Holly ;
Fernandes, Patricia ;
Le, Chap ;
Yueh, Bevan .
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2015, 5 (05) :435-440
[6]   Office-based sclerotherapy for recurrent epistaxis due to hereditary hemorrhagic telangiectasia: a pilot study [J].
Boyer, Holly ;
Fernandes, Patricia ;
Duran, Olga ;
Hunter, David ;
Goding, George .
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2011, 1 (04) :319-323
[7]   Meta-analysis of efficacy and safety of bevacizumab in the treatment of hereditary hemorrhagic telangiectasia epistaxis [J].
Chen, Huimin ;
Zhang, Zhiping ;
Chen, Xiaojuan ;
Wang, Chaoyu ;
Chen, Mingdi ;
Liao, Huizhao ;
Zhu, Jinru ;
Zheng, Zhenzhen ;
Chen, Riken .
FRONTIERS IN PHARMACOLOGY, 2023, 14
[8]   Epistaxis in hereditary hemorrhagic telangiectasia: an evidence based review of surgical management [J].
Chin, Christopher J. ;
Rotenberg, Brian W. ;
Witterick, Ian J. .
JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2016, 45
[9]   Treatments of Epistaxis in Hereditary Hemorrhagic Telangiectasia: Systematic Review and Network Meta-Analysis [J].
Chitsuthipakorn, Wirach ;
Hoang, Minh P. ;
Kanjanawasee, Dichapong ;
Seresirikachorn, Kachorn ;
Snidvongs, Kornkiat .
CURRENT ALLERGY AND ASTHMA REPORTS, 2023, 23 (12) :689-701
[10]  
Epperla N., 2014, BMJ Case Rep, V2014(1)